At the 2023 Grand Challenges Annual Meeting, Bill Gates, Co-chair of the Bill & Melinda Gates Foundation, announced new investments to advance access to mRNA research and vaccine manufacturing technology that will support low- and middle-income countries’ (LMICs) capacity to develop high-quality, lifesaving vaccines at scale.
Outlook to conduct another trial for wet AMD drug; Cara strikes new royalty deal
Outlook to conduct another trial for eye drug after rejection: Outlook Therapeutics announced Thursday that the FDA wants an additional study assessing bevacizumab in wet